×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EVAX – evaxion a/s - american depositary share (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EVAX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/27
08:16 am
evax
Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer [Yahoo! Finance]
Low
Report
Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer [Yahoo! Finance]
4/27
08:00 am
evax
Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer
Low
Report
Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer
4/24
08:20 am
evax
Evaxion A/S (EVAX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $16.00 price target on the stock.
Medium
Report
Evaxion A/S (EVAX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $16.00 price target on the stock.
4/17
08:02 pm
evax
Evaxion's AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial [Yahoo! Finance]
Low
Report
Evaxion's AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial [Yahoo! Finance]
4/17
03:10 pm
evax
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
Low
Report
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
4/17
03:00 pm
evax
New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma
Medium
Report
New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma
4/16
11:30 am
evax
Evaxion concludes Annual General Meeting
Low
Report
Evaxion concludes Annual General Meeting
4/7
08:00 am
evax
Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01
Medium
Report
Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/27
08:10 am
evax
Form 6-K Evaxion A/S For: Apr 27
Low
Report
Form 6-K Evaxion A/S For: Apr 27
4/24
05:20 pm
evax
Form 3 Evaxion A/S For: Apr 16 Filed by: Bitsch-Norhave Jens
Low
Report
Form 3 Evaxion A/S For: Apr 16 Filed by: Bitsch-Norhave Jens
4/22
07:00 am
evax
Form 6-K Evaxion A/S For: Apr 21
Medium
Report
Form 6-K Evaxion A/S For: Apr 21
4/17
03:30 pm
evax
Form 6-K Evaxion A/S For: Apr 17
Medium
Report
Form 6-K Evaxion A/S For: Apr 17
4/17
03:20 pm
evax
Form 6-K Evaxion A/S For: Apr 17
Low
Report
Form 6-K Evaxion A/S For: Apr 17
4/16
12:00 pm
evax
Form 6-K Evaxion A/S For: Apr 16
Low
Report
Form 6-K Evaxion A/S For: Apr 16
4/10
04:21 pm
evax
Form 3/A Evaxion A/S For: Mar 18 Filed by: Mattsson Andreas Holm
Low
Report
Form 3/A Evaxion A/S For: Mar 18 Filed by: Mattsson Andreas Holm
4/7
08:05 am
evax
Form 6-K Evaxion A/S For: Apr 07
Medium
Report
Form 6-K Evaxion A/S For: Apr 07
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: